• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Vet Sci . Serological survey of SARS-CoV-2 in companion animals in China

tetano

Editor, Senior Moderator
Front Vet Sci


. 2022 Nov 30;9:986619.
doi: 10.3389/fvets.2022.986619. eCollection 2022.
Serological survey of SARS-CoV-2 in companion animals in China


Aiping Wang[SUP] 1 [/SUP], Xifang Zhu[SUP] 1 [/SUP], Yumei Chen[SUP] 1 2 [/SUP], Yaning Sun[SUP] 2 [/SUP], Hongliang Liu[SUP] 1 2 [/SUP], Peiyang Ding[SUP] 1 2 [/SUP], Jingming Zhou[SUP] 1 [/SUP], Yankai Liu[SUP] 1 [/SUP], Chao Liang[SUP] 1 [/SUP], Jiajia Yin[SUP] 1 [/SUP], Gaiping Zhang[SUP] 1 [/SUP]



Affiliations

Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be transmitted from human to companion animals. The national wide serological surveillance against SARS-CoV-2 was conducted among pet animals, mainly in cats and dogs, 1 year after the first outbreak of COVID-19 in China. All sera were tested for SARS-CoV-2 IgG antibodies using an indirect enzyme linked immunosorbent assay (ELISA) based on the receptor binding domain (RBD) of spike protein. This late survey takes advantage of the short duration of the serological response in these animals to track recent episode of transmission. A total of 20,592 blood samples were obtained from 25 provinces across 7 geographical regions. The overall seroprevalence of SARS-CoV-2 infections in cats was 0.015% (2/13397; 95% confidence intervals (CI): 0.0, 0.1). The virus infections in cats were only detected in Central (Hubei, 0.375%) and Eastern China (Zhejiang, 0.087%) with a seroprevalence estimated at 0.090 and 0.020%, respectively. In dogs, the seroprevalence of SARS-CoV-2 infections was 0.014% (1/7159; 95% CI: 0.0, 0.1) in the entire nation, seropositive samples were limited to Beijing (0.070%) of Northern China with a prevalence of 0.054%. No seropositive cases were discovered in other geographic regions, nor in other companion animals analyzed in this study. These data reveal the circulation of SARS-CoV-2 in companion animals, although transmission of the virus to domestic cats and dogs is low in China, continuous monitoring is helpful for the better understand of the virus transmission status and the effect on animals.

Keywords: ELISA; SARS-CoV-2; colloidal gold test strips; companion animals; seroprevalence.
 
Back
Top Bottom